Navigation Links
ClearCanvas Releases First Commercial Version of Widely Used PACS; Integrated RIS/PACS to Follow
Date:5/31/2011

TORONTO, May 31, 2011 /PRNewswire/ -- ClearCanvas Inc., an innovative medical imaging informatics company, today announced the commercial release of their radiology PACS offering, ClearCanvas PACS, Team Edition. Following the April release of their first commercial radiology workstation product, this PACS release signifies the first commercial version of their widely accepted DICOM ImageServer software, previously only offered as an open source application.

With the release of the PACS, Team Edition, small radiology practices now have access to a robust FDA cleared ClearCanvas product suite designed with them in mind.  Building on the open source ImageServer, the Team Edition includes a concurrent workstation licensing model, unlimited web-based image viewing, roaming user profiles, JPEG2000 compression support, and centralized audit logs. In addition, the Team Edition workstation includes all of the same features as the Clinical Edition, including Media Writing, DICOM Print, and PET/CT Fusion.

The ClearCanvas PACS, Team Edition is available for purchase through a small but rapidly growing number of resellers worldwide.

"My vision for ClearCanvas has always been to offer integrated workflow solutions to the medical imaging community - and not just image viewing applications," says Norman Young, CEO. "With features like roaming user profiles and web-based access to images, the Team Edition represents the next step in that direction. We are very excited about how the Team Edition will empower small radiology practices all over the world."

ClearCanvas expects a commercial release of their integrated RIS/PACS in early 2012. Additional versions of both the Workstation and the PACS are already planned for 2011; product upgrades and technical support are included free of charge during the first license year. ClearCanvas will continue to release new versions of their open source software as well.

ClearCanvas Inc. develops innovativ
'/>"/>

SOURCE ClearCanvas Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ClearCanvas Releases First Commercial Version of Popular Clinical Radiology Workstation; PACS and RIS to Follow
2. Aureus Pharma Releases AurPROFILER(R) - a New and Powerful Pharmacology Profiling Solution
3. Aureus Pharma Releases New Unified Knowledge Database
4. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
5. Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials
6. Presidio Pay Advisors Releases Salary GPS Tool
7. Techne Corporation Releases Unaudited First Quarter Results for Fiscal Year 2009
8. BioWisdom Releases Text Analytics Version of OmniViz for Patent Specialists
9. T-System Releases The T SystemEV(R) 2.6.3, Featuring New Meds/Allergies Notification, Automated Charge Capture
10. BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
11. Sigma-Aldrich Releases WTA2, a Transplex Whole Transcriptome Amplification Technology for Degraded RNA Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015 Sinovac Biotech Ltd. (Nasdaq: SVA), a ... its unaudited financial results for the fourth quarter and ... Quarter 2014 Financial Highlights(Compared to the fourth quarter 2013) ... decrease of 11.4% from $22.9 million in the prior ... H5N1 pandemic influenza vaccine of $0.1 million in the ...
(Date:4/17/2015)... ALTO, Calif. , April 17, 2015 ... has received a SBIR grant from the ... the National Institutes of Health (NIH). The ... research efforts in the development of breakthrough ... genomes using specially fabricated substrates. Centrillion has ...
(Date:4/17/2015)... , April 17, 2015  US-Australian drug discovery ... a Memorandum of Understanding with the Feinstein Institute ... New York to collaborate with the ... The collaboration brings together the drug ... clinical expertise of the Feinstein Institute in neurosciences ...
(Date:4/16/2015)... and OSAKA, Japan , ... Research Application (CiRA) of Kyoto University and Takeda ... will work together to develop clinical applications of ... heart failure, diabetes mellitus, neurological disorders and cancer ... Applications" (T-CiRA) is designed to expedite multiple research ...
Breaking Biology Technology:Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 3Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 4Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 5Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 6Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 7Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 8Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 9Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 10Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 11Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 12Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 13Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 14Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 15Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 16Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 17Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 18Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3
... NEW YORK, Feb. 4 Emisphere Technologies, Inc.,(Nasdaq: ... unique and,improved delivery of therapeutic molecules using its eligen(R) ... BIO CEO & Investor,Conference on February 12, 2008 at ... V. Novinski, President and Chief Executive Officer of,Emisphere, will ...
... AMDL, Inc. (Amex:,ADL), headquartered in Tustin, California, ... through its wholly owned subsidiary Jade,Pharmaceutical Inc. ... with Jade, engages in the development, manufacture ... diagnostic products. The,Company announced today that JPI,s ...
... - Conference Call Scheduled for 5 February 2008, 09:00 ... ... BRISBANE, Australia, Feb. 4 Progen,Pharmaceuticals Limited (ASX: PGL; Nasdaq: ... to acquire privately-held U.S.,oncology company CellGate, Inc. The CellGate acquisition ...
Cached Biology Technology:Emisphere Technologies to Present at BIO CEO & Investor Conference on February 12 2AMDL Receives a Significant Updated Appraisal of Its JJB China Production Facilities 2Progen Expands Drug Development Pipeline Through Acquisition of CellGate 2Progen Expands Drug Development Pipeline Through Acquisition of CellGate 3Progen Expands Drug Development Pipeline Through Acquisition of CellGate 4Progen Expands Drug Development Pipeline Through Acquisition of CellGate 5
(Date:4/13/2015)... 13, 2015 According to ... Biometrics Market Forecast & Opportunities, 2020", the global biometrics ... around 14% till 2020. The biometrics market is ... implementation and review of biometric management systems. The ... products with greater efficiency, are resulting in increasing ...
(Date:4/8/2015)...  Infinisource, a leading provider of SaaS-based Human Capital ... leading supplier of biometric identification and security solutions, ... advanced biometrically-enabled time clock, the companies announced today. ... setting a bold, new standard for the collection ... and mid-size employer. When connected to the iSolved ...
(Date:4/2/2015)... GOTHENBURG, Sweden , April 2, 2015 ... revenues for Q1 2015 attributed to somewhat higher than ... company in the year-end report 2014 that revenues for ... MSEK that the company reported for Q4 2014. The ... continue to be negative. The complete interim report will ...
Breaking Biology News(10 mins):Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Revises Revenues for Q1 2015 2
... a chronic swelling condition that can appear after ... million breast cancer survivors. Although lymphedema can cause ... chest, there is no national standard of diagnosis ... leading the American Lymphedema Framework Project (ALFP), a ...
... On the first anniversary of the American Recovery ... the nation,s research universities today provided nearly 100 examples ... is paying outsize short- and long-term dividends for the ... ARRA, $21.5 billion is allocated for research and science ...
... State University graduate students teaching introductory biology labs are ... engage their students in critical thinking, and even craft ... a Graduate Teacher Training Program supported by a portion ... university has received. The training program is operated by ...
Cached Biology News:Researchers develop standard of care for breast cancer survivors with lymphedema 2Universities highlight benefits of stimulus research funding 2Universities highlight benefits of stimulus research funding 3Oregon State trains graduate students to be better TAs 2Oregon State trains graduate students to be better TAs 3Oregon State trains graduate students to be better TAs 4
Human PLUNC MAb (Clone 252512)...
... to GRASP1 ( Abpromise for ... Antigen: Synthetic peptide corresponding to ... terminal region of rat GRASP1, conjugated ... Entrez GeneID: 56850 ...
Homo sapiens CDC23 (cell division cycle 23, yeast, homolog),...
Terrific Broth, 1 kg. Mixture of casein peptone, yeast extract, K2HPO4, and KH2PO4.Used at 47 g/l for E. coli growth with higher cell densities. Category: Nucleotides & Enzymes & Biochemicals, Ultrap...
Biology Products: